American Century Companies’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,334
| Closed | -$123K | – | 2931 |
|
|
2024
Q1 | $123K | Sell |
12,334
-15,464
| -56% | -$154K | ﹤0.01% | 2841 |
|
|
2023
Q4 | $274K | Sell |
27,798
-58,127
| -68% | -$573K | ﹤0.01% | 2605 |
|
|
2023
Q3 | $657K | Buy |
85,925
+75,712
| +741% | +$579K | ﹤0.01% | 2162 |
|
|
2023
Q2 | $76.3K | Buy |
+10,213
| New | +$76.3K | ﹤0.01% | 2718 |
|
|
2022
Q2 | – | Sell |
-301,984
| Closed | -$2.16M | – | 2377 |
|
|
2022
Q1 | $2.16M | Sell |
301,984
-1,067
| -0.4% | -$7.64K | ﹤0.01% | 1382 |
|
|
2021
Q4 | $5.19M | Buy |
303,051
+151,692
| +100% | +$2.6M | ﹤0.01% | 1046 |
|
|
2021
Q3 | $3.48M | Buy |
+151,359
| New | +$3.48M | ﹤0.01% | 1119 |
|